Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Oct. 9, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 9, 2013

Alkermes, Allegro, Bayer, BDSI, Medivir, Pfizer, Portola, and The Medicines Company

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Medivir posts new seven-day data of MIV-711 in osteoarthritis . . . read more

Portola begins proof-of-concept for SyK/JAK inhibitor . . . read more

Phase II
Alkermes aligns with FDA on development plans . . . read more

Allegro cleared for ophthalmic trials . . . read more

Phase III
Pfizer releases topline data for JAK inhibitor . . . read more

TMC enrolls first Angiomax PEI patient . . . read more

Filings
Bayer PAH/CTEPH drug approved . . . read more

BDSI Files Bunavail NDA . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics